Alister Life Sciences LLP
Pharma Manufacturer
Call us
08045814173
Alister Life Sciences LLP
English
Spanish
French
German
Italian
Chinese (Simplified)
Japanese
Korean
Arabic
Portuguese
Send Inquiry
Tretinoin Topical Treatment Of Acne Vulgaris Cream
Product Details:
- Application For external use
- Formulations Type External Use Drugs
- Formulations Form Cream
- Gender/Age Group Adult
- Dosage Guidelines As per suggestion
- Storage Instructions Room temperature
- Click to View more
X
Tretinoin Topical Treatment Of Acne Vulgaris Cream Price And Quantity
- 10 Pack
Tretinoin Topical Treatment Of Acne Vulgaris Cream Product Specifications
- As per suggestion
- For external use
- External Use Drugs
- Adult
- Cream
- Room temperature
Tretinoin Topical Treatment Of Acne Vulgaris Cream Trade Information
- Cash in Advance (CID)
- 1000 Pack Per Month
- 2-10 Days
- All India
Product Description
Tretinoin Topical Treatment Of Acne Vulgaris Cream is a highly effective solution designed for adults to manage and treat Acne Vulgaris. This cream is crafted in a formulation specifically suited for external use as a part of commercial skincare applications. It is prepared to deliver therapeutic benefits when applied under dosage guidelines provided by a healthcare professional. Stored at room temperature to maintain its effectiveness, the cream is easy to use and integrates seamlessly into daily skincare routines. Its topical application addresses acne concerns, promoting a clearer and healthier complexion. This product is ideal for businesses seeking reliable skincare solutions that meet clinical standards.
FAQs of Tretinoin Topical Treatment Of Acne Vulgaris Cream:
Tell us about your requirement
Price:
Quantity
Select Unit
- 50
- 100
- 200
- 250
- 500
- 1000+
Additional detail
Mobile number
Email
Other Products in 'Pharmaceutical Cream and ointment' category
Alister Life Sciences LLP
All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Private Limited.
Developed and Managed by Infocom Network Private Limited.
